Source:http://linkedlifedata.com/resource/pubmed/id/15664133
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2005-1-24
|
pubmed:abstractText |
In order to investigate the effects of EDTA and boric acid (EDTA/boric acid) on the corneal penetration of CS-088, an ophthalmic agent, the apparent permeability coefficient of CS-088 in the presence of EDTA/boric acid across the isolated corneal membranes of rabbits was measured using an in vitro penetration chamber system. FITC-dextran (M.W. 4400) and an electrical method based on membrane resistance were used to provide a quantitative assessment of the enhancing effect of EDTA/boric acid. The corneal penetration of CS-088 was significantly enhanced in the presence of EDTA/boric acid by approximately 1.6-fold. The permeability-enhancing effect of EDTA/boric acid was apparently synergistic and concentration-dependent on both EDTA and boric acid. The penetration of FITC-dextran, a paracellular marker, and electrical resistance of corneal membranes were not affected in the presence of EDTA/boric acid. Furthermore, no enhancing effect of EDTA/boric acid was observed in de-epithelialized corneas, although de-epithelialized corneas exhibited a markedly higher permeability of CS-088 that was 24-fold greater than that for intact corneas. In conclusion, EDTA/boric acid synergistically enhances the transcellular permeability of CS-088 in the outer layer but not in the inner layers of the corneal membrane.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor...,
http://linkedlifedata.com/resource/pubmed/chemical/Boric Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Edetic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles,
http://linkedlifedata.com/resource/pubmed/chemical/boric acid,
http://linkedlifedata.com/resource/pubmed/chemical/olmesartan
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0378-5173
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
16
|
pubmed:volume |
290
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
83-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15664133-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:15664133-Animals,
pubmed-meshheading:15664133-Boric Acids,
pubmed-meshheading:15664133-Cornea,
pubmed-meshheading:15664133-Drug Synergism,
pubmed-meshheading:15664133-Edetic Acid,
pubmed-meshheading:15664133-Imidazoles,
pubmed-meshheading:15664133-Male,
pubmed-meshheading:15664133-Permeability,
pubmed-meshheading:15664133-Rabbits,
pubmed-meshheading:15664133-Tetrazoles
|
pubmed:year |
2005
|
pubmed:articleTitle |
Synergistic effect of EDTA and boric acid on corneal penetration of CS-088.
|
pubmed:affiliation |
Pharmaceutical Development Laboratories, Sankyo Co., Ltd. 1-12-1, Shinomiya, Hiratsuka, Kanagawa 254-0014, Japan. tkikuc@sankyo.co.jp
|
pubmed:publicationType |
Journal Article,
Comparative Study
|